Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. [PDF]
, 2011 Thrombotic risk increases in elderly, therefore, the understanding of the genetic predisposition of hypercoagulability could make the difference in the prevention of venous and/or arterial thrombotic events.
Branzi, A +8 more
core +1 more source
Medicinski glasnik, 2018 Aim To investigate association of factor V Leiden, prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
A. Jusic +4 more
semanticscholar +1 more source
Factor V Leiden and venous thrombosis: First case report from Iraq
مجلة كلية الطب, 2005 Background: Factor V Leiden mutation is the most common cause of hereditary thrombophilia . this mutation was found to be highly prevalent in the Eastern Mediterranean region , with recently reported prevalence of 3% in random Iraqi blood donors.
Nasir AL-Allawi +3 more
doaj +1 more source
Prevalence and Clinical Significance of Factor V Leiden Mutation in Egyptian Preeclamptic Women [PDF]
International Journal of Medical Arts, 2021 Background: Factor V [Leiden] mutation, also known as activated protein-C resistance, is the most common of the inherited thrombophilias. Aim of the work: The present study aimed to ass the prevalence of factor V Leiden mutation in a group of Egyptian ...
Ahmed Alsheikh +2 more
doaj +1 more source
Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization [PDF]
, 2020 Background: Requests to test for thrombophilia in the clinical context are often not evidence-based. Aim: To define the role of a series of prothrombotic gene variants in a large population of patients with different venous thromboembolic diseases ...
AMATO, FELICE +9 more
core +1 more source
Haematologica, 2008 Background Routine analyses for thrombophilia include determination of the presence of factor V Leiden and prothrombin 20210A polymorphisms. However, the usefulness of these determinations is controversial and the clinical benefit remains questioned ...
Antonia Miñano +11 more
doaj +1 more source
Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis. [PDF]
, 2009 The aim of this study was to perform a meta-analysis of the association between the factor V Leiden polymorphism (FVL) and thrombosis among patients with systemic lupus erythematosus (SLE) and/or antiphospholipid antibody (aPL) positivity.
Barton, JL +6 more
core +2 more sources
Current evidence for outcomes of free-flap reconstruction in factor V Leiden patients
Australasian Journal of Plastic Surgery, 2019 **Background**: Factor V Leiden is the most common form of inherited thrombophilic syndrome, affecting 5 per cent of Caucasians. While increased rates of venous thromboembolic complications have been regularly reported in factor V Leiden patients, little
Isobel Yeap +4 more
doaj +1 more source
Prothrombin G20210A and Factor V Leiden mutations in ischemic arterial stroke
Van Tıp Dergisi, 2018 INTRODUCTION: Ischemic stroke remains an important public health problem in all over world. It is wellknown that, some type of genetic mutations such as factor V Leiden and prothrombin G20210A contribute to the risk of ischemic venous stroke.
Hafize Nalan Güneş
doaj +1 more source
Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population [PDF]
Iranian Journal of Reproductive Medicine, 2012 Background: Role of genetic factors in etiology of preeclampsia is not confirmed yet.Objective: Gene defect frequency varies in different geographic areas as well as ethnic groups.
Azadeh Azinfar +4 more
doaj